Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
1 file | 32.49 KB
Add to list
  1. Search results
  2. Hamametitannin based adjuvants in the...

Hamametitannin based adjuvants in the Vancomycin treatment of Staphylococcus Aureus infections: from a natural product towards a more druglike lead compound

Martijn Risseeuw (UGent) and Serge Van Calenbergh (UGent)
(2015) Frontiers in Medicinal Chemistry, Abstracts. p.240-240
Author
Organization

Downloads

  • Download
    Abstract Martijn Risseeuw.docx
    • full text
    • |
    • open access
    • |
    • Word
    • |
    • 32.49 KB

Citation

Please use this url to cite or link to this publication:

MLA
Risseeuw, Martijn, and Serge Van Calenbergh. “Hamametitannin Based Adjuvants in the Vancomycin Treatment of Staphylococcus Aureus Infections: From a Natural Product Towards a More Druglike Lead Compound.” Frontiers in Medicinal Chemistry, Abstracts. Scientific Conference Producers, 2015. 240–240. Print.
APA
Risseeuw, M., & Van Calenbergh, S. (2015). Hamametitannin based adjuvants in the Vancomycin treatment of Staphylococcus Aureus infections: from a natural product towards a more druglike lead compound. Frontiers in Medicinal Chemistry, Abstracts (pp. 240–240). Presented at the Frontiers in Medicinal Chemistry 2015 (FMC 2015), Scientific Conference Producers.
Chicago author-date
Risseeuw, Martijn, and Serge Van Calenbergh. 2015. “Hamametitannin Based Adjuvants in the Vancomycin Treatment of Staphylococcus Aureus Infections: From a Natural Product Towards a More Druglike Lead Compound.” In Frontiers in Medicinal Chemistry, Abstracts, 240–240. Scientific Conference Producers.
Chicago author-date (all authors)
Risseeuw, Martijn, and Serge Van Calenbergh. 2015. “Hamametitannin Based Adjuvants in the Vancomycin Treatment of Staphylococcus Aureus Infections: From a Natural Product Towards a More Druglike Lead Compound.” In Frontiers in Medicinal Chemistry, Abstracts, 240–240. Scientific Conference Producers.
Vancouver
1.
Risseeuw M, Van Calenbergh S. Hamametitannin based adjuvants in the Vancomycin treatment of Staphylococcus Aureus infections: from a natural product towards a more druglike lead compound. Frontiers in Medicinal Chemistry, Abstracts. Scientific Conference Producers; 2015. p. 240–240.
IEEE
[1]
M. Risseeuw and S. Van Calenbergh, “Hamametitannin based adjuvants in the Vancomycin treatment of Staphylococcus Aureus infections: from a natural product towards a more druglike lead compound,” in Frontiers in Medicinal Chemistry, Abstracts, Antwerp, Belgium, 2015, pp. 240–240.
@inproceedings{6935193,
  author       = {Risseeuw, Martijn and Van Calenbergh, Serge},
  booktitle    = {Frontiers in Medicinal Chemistry, Abstracts},
  language     = {eng},
  location     = {Antwerp, Belgium},
  pages        = {240--240},
  publisher    = {Scientific Conference Producers},
  title        = {Hamametitannin based adjuvants in the Vancomycin treatment of Staphylococcus Aureus infections: from a natural product towards a more druglike lead compound},
  year         = {2015},
}